Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2007 Filed Feb 2, 2007 00:19 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 16,623 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-006575 · a4.xml · derivative · entry 4 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,938 Underlying: Common shares · 16,623 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:19 UTC |
Fiorentino Edward JSenior Vice President
|
Tax withholdingCommon shares without par value | 14,107 | $52.66 | $742,874.62 |
DisclosureSEC source: 0001104659-07-006575 · a4.xml · nonDerivative · entry 2 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,521 Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:19 UTC |
Fiorentino Edward JSenior Vice President
|
Exercise / conversionCommon shares without par value | 16,623 | $41.03 | $682,069.95 |
DisclosureSEC source: 0001104659-07-006575 · a4.xml · nonDerivative · entry 1 Fiorentino Edward J · CIK 0001347046 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 17,274 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · derivative · entry 15 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,274 Underlying: common shares · 17,274 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 17,965 | $0.00 Strike: $52.66 | $0.00 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · derivative · entry 14 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,965 Underlying: common shares · 17,965 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,701 | $0.00 Strike: $44.96 | $0.00 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · derivative · entry 13 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,701 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,137 | $0.00 Strike: $39.72 | $0.00 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · derivative · entry 12 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 5,137 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 20,339 | $0.00 Strike: $41.14 | $0.00 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · derivative · entry 11 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98 Underlying: common shares · 20,339 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 21,281 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · derivative · entry 10 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,639 Underlying: common shares · 21,281 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
SaleCommon shares without par value | 7,838 | $53.11 | $416,299.69 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · nonDerivative · entry 6 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,521 Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
Tax withholdingCommon shares without par value | 35,239 | $52.66 | $1,855,685.74 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · nonDerivative · entry 5 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,359 Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,701 | $44.96 | $121,436.96 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · nonDerivative · entry 4 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,137 | $39.72 | $204,021.09 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · nonDerivative · entry 3 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 20,339 | $41.14 | $836,837.99 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · nonDerivative · entry 2 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2007 Filed Feb 2, 2007 00:21 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 21,281 | $41.03 | $873,195.61 |
DisclosureSEC source: 0001104659-07-006576 · a4.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,479 | $0.00 Strike: $52.25 | $0.00 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,479 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,819 | $0.00 Strike: $40.93 | $0.00 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,819 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
SaleCommon shares without par value | 8,298 | $52.57 | $436,225.86 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,986 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 5,479 | $52.25 | $286,293.64 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
LIEPMANN HOLGER AExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,819 | $40.93 | $115,376.88 |
DisclosureSEC source: 0001104659-07-006230 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,909 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006228 · a4.xml · derivative · entry 10 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,909 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
Schumacher Laura JSenior Vice President
|
GrantOption (right to buy) · Derivative | 1,735 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006228 · a4.xml · derivative · entry 9 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,735 Underlying: Common shares · 1,735 shares Expires 2008-02-12 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,623 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006228 · a4.xml · derivative · entry 8 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,623 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,166 | $0.00 Strike: $31.43 | $0.00 |
DisclosureSEC source: 0001104659-07-006228 · a4.xml · derivative · entry 7 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,166 shares Expires 2007-06-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
Schumacher Laura JSenior Vice President
|
SaleCommon shares without par value | 2,909 | $52.45 | $152,577.05 |
DisclosureSEC source: 0001104659-07-006228 · a4.xml · nonDerivative · entry 5 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,704 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,909 | $34.77 | $101,153.78 |
DisclosureSEC source: 0001104659-07-006228 · a4.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
Schumacher Laura JSenior Vice President
|
Tax withholdingCommon shares without par value | 2,432 | $52.55 | $127,801.60 |
DisclosureSEC source: 0001104659-07-006228 · a4.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,704 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionCommon shares without par value | 2,623 | $34.77 | $91,208.79 |
DisclosureSEC source: 0001104659-07-006228 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
Schumacher Laura JSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,166 | $31.43 | $36,643.88 |
DisclosureSEC source: 0001104659-07-006228 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantOption (right to buy) · Derivative | 20,839 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,839 Underlying: common shares · 20,839 shares Expires 2010-07-31 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
GrantOption (right to buy) · Derivative | 21,357 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,357 Underlying: common shares · 21,357 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 25,240 | $0.00 Strike: $39.50 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,681 Underlying: common shares · 25,240 shares Expires 2010-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionOption (right to buy) · Derivative | 25,298 | $0.00 Strike: $40.95 | $0.00 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · derivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 25,298 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Tax withholdingCommon shares without par value | 42,196 | $52.55 | $2,217,399.80 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,359 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 25,240 | $39.50 | $997,007.76 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:13 UTC |
GONZALEZ RICHARD ADirector · President and COO
|
Exercise / conversionCommon shares without par value | 25,298 | $40.95 | $1,035,879.74 |
DisclosureSEC source: 0001104659-07-006229 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption right to buy · Derivative | 915 | $0.00 Strike: $41.01 | $0.00 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · derivative · entry 10 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 915 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from section 16(b) under Rule 16 b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption right to buy · Derivative | 1,516 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · derivative · entry 9 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,516 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from section 16(b) under Rule 16 b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption right to buy · Derivative | 4,293 | $0.00 Strike: $45.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · derivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,293 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from section 16(b) under Rule 16 b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption right to buy · Derivative | 620 | $0.00 Strike: $41.92 | $0.00 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 620 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from section 16(b) under Rule 16 b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 7,344 | $52.62 | $386,441.28 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,897 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 915 | $41.01 | $37,524.15 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 1,516 | $42.42 | $64,312.66 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 4,293 | $45.77 | $196,483.31 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 620 | $41.92 | $25,987.36 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 33,180 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · derivative · entry 15 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,180 Underlying: Common Shares · 33,180 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 20,882 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · derivative · entry 14 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,882 Underlying: Common shares · 20,882 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 26,572 | $0.00 Strike: $52.55 | $0.00 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · derivative · entry 13 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,572 Underlying: Common shares · 26,572 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 39,015 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · derivative · entry 12 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,507 Underlying: Common Shares · 39,015 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 24,684 | $0.00 Strike: $41.07 | $0.00 |
DisclosureSEC source: 0001104659-07-006232 · a4.xml · derivative · entry 11 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 24,684 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.